Human Placental aqueous Extract is a very safe drug.The We the team of IICB, Kolkata are working with the drug ‘Placentrex’ since 1999 with extension in every alternate year. A committee constituted by experts approved renewal of the project. Ours is a CSIR owned biomedical research institute of national importance. As per CSIR guidelines on human and animal ethics, it is not possible to undertake any research in the institute, which is hazardous or unsafe to human or animal health or the environment.
Two research scholar Dr. Sangeeta Nath and Ms. Debashree De, were awarded CSIR-senior research fellowship for continuation of their work on ‘Placentrex’ in 2004 and 2007 respectively. The expert committee of CSIR, New Delhi, awarded fellowships after extensive reviewing of research proposals. The committee members were fully aware of the manufacturing of the drug. Three Thesises describing research on ‘Placentrex’ have been submitted to Jadavpur University for the award of Ph.D. degree by National and foreign examiners who are experts in the respective fields have evaluated these theses. Nobody raised doubts about bio-safety of the starting materials. Since 1999, in many occasions we presented research work in front of national and international audiences. The question of safety of the drug has never been raised. Once the germination period was over, we are publishing research articles on ‘Placentrex’ since 2004, in different national and international peer-reviewed journals. It should be noted that no journal would accept a manuscript until the ethical aspects like safety of products are satisfied. Thus it is clear that identified experts have endorsed the safety of the drug in a worldwide fashion. Significantly, a review article is also in print.
1. J. Pharma. Biomed. Res. [2004] USA
2. J. Pharma. Biomed. Res. (2004) USA
3. J. Chromat. B (2005)Netherlands
4. Current. Science (2005)India
5. Inter. Immunopharmacol. (2006) UK
6. Indian J. Expt. Biol. (2007) India
7. J. Chromat. B (2009)Netherlands
8. J. Wound Care (2009)U.K.
9. Physiol. Update (2009) India
10. J. Cell. Physiol. (2010)USA
In conclusion, it may be summarized that experts of biomedical research have approved the safety of the drug ‘Placentrex’ worldwide since 1999 i.e., as long as we are associated with its research. None of these experts are beneficiaries of ‘Placentrex’ research. So the concern for safety of the drug does not stand on any foundation.